No Data
No Data
Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ
The potential rescheduling of cannabis in the U.S. and the growing demand in Germany positions InterCure (NASDAQ:INCR), the leading seller of pharmaceutical cannabis outside North America, to capitali
Leading Analyst Gives InterCure Overweight Rating, Noting 5x Returns Potential
InterCure Ltd. (NASDAQ: INCR), a prominent player in the global medical cannabis industry, has received an Overweight rating from Zuanic & Associates, a highly respected firm, which are widely considered leading the field of cannabis and psychedelics.
Intercure Ltd. Files SEC Report, Ensures Transparency
InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference
InterCure Ltd. (NASDAQ:INCR) (TASE: INCR) (dba Canndoc), the leading medical cannabis company outside of North America, today announced that it will participate in the Canaccord Genuity 8th Annual Global Cannabis
CRVS, CTMX and NRXP Are Among Premarket Gainers
InterCure Reports FY Results